Helen Diller Medical Center at Parnassus Heights — San Francisco, California

Helen Diller Medical Center at Parnassus Heights is a clinical research site located in San Francisco, California, United States 94143.

Crixeo Clinical Trials Trust Score: 11/100 (FAILING). This profile has not yet been claimed by the site owner.

Helen Diller Medical Center at Parnassus Heights has participated in 2 clinical trials with 2 currently active.

Therapeutic areas: Autosomal Dominant Polycystic Kidney Disease (ADPKD), Proteinuric Kidney Disease.

Sponsors: Vertex Pharmaceuticals Incorporated.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in San Francisco

Browse all research sites in California · View every site in San Francisco

Sponsor Feasibility Report

Trust Score: 11/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Helen Diller Medical Center at Parnassus Heights?

Helen Diller Medical Center at Parnassus Heights has a Crixeo Trust Score of 11/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Helen Diller Medical Center at Parnassus Heights conducted?

Helen Diller Medical Center at Parnassus Heights has 2 clinical trials on record, with 2 currently active. Their work covers Autosomal Dominant Polycystic Kidney Disease (ADPKD), Proteinuric Kidney Disease.

Is Helen Diller Medical Center at Parnassus Heights accredited by Crixeo Clinical Trials?

Helen Diller Medical Center at Parnassus Heights has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Helen Diller Medical Center at Parnassus Heights?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.